Caribou Biosciences (CRBU) Change in Account Payables (2020 - 2026)
Caribou Biosciences (CRBU) reported Change in Account Payables of -$2.2 million for Q1 2026, down 258.12% year-over-year from $1.4 million in Q1 2025, and down 215.69% quarter-over-quarter from $1.9 million in Q4 2025.
Caribou Biosciences (CRBU) Change in Account Payables (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 7 years of Change in Account Payables data on file, last reported at -$2.2 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$2.2 million, down 258.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$370000.0 (up 77.84% YoY), and the FY2025 annual result was $3.3 million, up 1019.21% from the prior year.
- Change in Account Payables eased to -$2.2 million in Q1 2026 per CRBU's latest filing, from $1.9 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.7 million in Q1 2024 and troughed at -$2.4 million in Q2 2024.
- A 5-year average of -$13058.8 and a median of -$153000.0 in 2022 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables tumbled 5275.68% in 2022, then surged 937.99% in 2025.
- A 5-year view of Change in Account Payables shows it stood at -$153000.0 in 2022, then jumped by 577.12% to $730000.0 in 2023, then tumbled by 131.37% to -$229000.0 in 2024, then surged by 937.99% to $1.9 million in 2025, then sank by 215.69% to -$2.2 million in 2026.
- Business Quant data shows CRBU's Change in Account Payables at -$2.2 million in Q1 2026, $1.9 million in Q4 2025, and $561000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Caribou Biosciences | 156.73 Mn | 39.11 Mn | - | -2.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.22 Mn |
| Mar 31, 2026 | -2.22 Mn |
| Dec 31, 2025 | 1.92 Mn |
| Dec 31, 2025 | 1.92 Mn |
| Sep 30, 2025 | 561,000.00 |
| Sep 30, 2025 | 561,000.00 |
| Jun 30, 2025 | -630,000.00 |
| Jun 30, 2025 | -630,000.00 |
| Mar 31, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | -229,000.00 |
| Dec 31, 2024 | -229,000.00 |
| Sep 30, 2024 | -477,000.00 |
| Sep 30, 2024 | -477,000.00 |
| Jun 30, 2024 | -2.37 Mn |
| Jun 30, 2024 | -2.37 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 730,000.00 |
| Dec 31, 2023 | 730,000.00 |